The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder

Frontiers in Behavioral Neuroscience

Volumn , Issue JUL, 2013, Pages

  Trezza, Viviana ^a   Campolongo, Patrizia ^b  

^a ROMA TRE UNIVERSITY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Anxiety; Cannabis; Endocannabinoids; Memory; Trauma exposure

Indexed keywords

ANTICONVULSIVE AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CANNABIS; ENDOCANNABINOID; ENDOCANNABINOID DEGRADATION INHIBITOR; MONOAMINE OXIDASE INHIBITOR; PSYCHOTROPIC AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

ADAPTATION; AFFECT; ARTICLE; COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE CONTROL; DRUG TARGETING; EMOTIONAL DISORDER; HUMAN; MEMORY; MEMORY CONSOLIDATION; MEMORY EXTINCTION; MEMORY RETRIEVAL; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; REGULATORY MECHANISM;

EID: 84880622031     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2013.00100     Document Type: Article

References (82)

1. Akirav, I. (2011). The role of cannabinoids in modulating emotional and non-emotional memory processes in the hippocampus. Front Behav Neurosci 5, 34.
2. Albucher, R.C., and Liberzon, I. (2002). Psychopharmacological treatment in PTSD: a critical review. J Psychiatr Res 36, 355-367.
3. Ashton, J.C. (2012). Synthetic cannabinoids as drugs of abuse. Curr Drug Abuse Rev 5, 158-168.
4. Atsak, P., Roozendaal, B., and Campolongo, P. (2012). Role of the endocannabinoid system in regulating glucocorticoid effects on memory for emotional experiences. Neuroscience 204, 104-116.
5. Berardi, A., Trezza, V., and Campolongo, C. (2012). Modeling specific phobias and posttraumatic stress disorder in rodents: the challenge to convey both cognitive and emotional features. Rev Neurosci 23, 645-657.
6. Bergamaschi, M.M., Queiroz, R.H., Chagas, M.H., De Oliveira, D.C., De Martinis, B.S., Kapczinski, F., Quevedo, J., Roesler, R., Schroder, N., Nardi, A.E., Martin-Santos, R., Hallak, J.E., Zuardi, A.W., and Crippa, J.A. (2011). Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients. Neuropsychopharmacology 36, 1219-1226.
7. Bitencourt, R.M., Pamplona, F.A., and Takahashi, R.N. (2008). Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats. Eur Neuropsychopharmacol 18, 849-859.
8. Bonn-Miller, M.O., Vujanovic, A.A., and Drescher, K.D. (2011). Cannabis use among military veterans after residential treatment for posttraumatic stress disorder. Psychol Addict Behav 25, 485-491.
9. Bonn-Miller, M.O., Vujanovic, A.A., Feldner, M.T., Bernstein, A., and Zvolensky, M.J. (2007). Posttraumatic stress symptom severity predicts marijuana use coping motives among traumatic event-exposed marijuana users. J Trauma Stress 20, 577-586.
10. Bortolato, M., Campolongo, P., Mangieri, R.A., Scattoni, M.L., Frau, R., Trezza, V., La Rana, G., Russo, R., Calignano, A., Gessa, G.L., Cuomo, V., and Piomelli, D. (2006). Anxiolytic-like properties of the anandamide transport inhibitor AM404. Neuropsychopharmacology 31, 2652-2659
11. Bremner, J.D., Elzinga, B., Schmahl, C., and Vermetten, E. (2008). Structural and functional plasticity of the human brain in posttraumatic stress disorder. Prog Brain Res 167, 171-186
12. Bremner, J.D., Southwick, S.M., Darnell, A., and Charney, D.S. (1996). Chronic PTSD in Vietnam combat veterans: course of illness and substance abuse. Am J Psychiatry 153, 369-375.
13. Brewin, C.R. (2001). A cognitive neuroscience account of posttraumatic stress disorder and its treatment. Behav Res Ther 39, 373-393.
14. Campolongo, P., Morena, M., Scaccianoce, S., Trezza, V., Chiarotti, F., Schelling, G., Cuomo, V., and Roozendaal, B. (2013). Novelty-Induced Emotional Arousal Modulates Cannabinoid Effects on Recognition Memory and Adrenocortical Activity. Neuropsychopharmacology. 38, 1276-1286.
15. Campolongo, P., Ratano, P., Manduca, A., Scattoni, M.L., Palmery, M., Trezza, V., and Cuomo, V. (2012). The endocannabinoid transport inhibitor AM404 differentially modulates recognition memory in rats depending on environmental aversiveness. Front Behav Neurosci 6, 11.
16. Campolongo, P., Roozendaal, B., Trezza, V., Hauer, D., Schelling, G., Mcgaugh, J.L., and Cuomo, V. (2009a). Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory. Proc Natl Acad Sci. USA 106, 4888-4893.
17. Campolongo, P., Trezza, V., Cassano, T., Gaetani, S., Morgese, M.G., Ubaldi, M., Soverchia, L., Antonelli, T., Ferraro, L., Massi, M., Ciccocioppo, R., and Cuomo, V. (2007). Perinatal exposure to delta-9-tetrahydrocannabinol causes enduring cognitive deficits associated with alteration of cortical gene expression and neurotransmission in rats. Addict Biol 12, 485-495.
18. Campolongo, P., Trezza, V., Palmery, M., Trabace, L., and Cuomo, V. (2009b). Developmental exposure to cannabinoids causes subtle and enduring neurofunctional alterations. Int Rev Neurobiol 85, 117-133.
19. Campolongo, P., Trezza, V., Ratano, P., Palmery, M., and Cuomo, V. (2011). Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents. Psychopharmacology (Berl) 214, 5-15.
20. Cohen, H., Kaplan, Z., Matar, M.A., Loewenthal, U., Kozlovsky, N., and Zohar, J. (2006). Anisomycin, a protein synthesis inhibitor, disrupts traumatic memory consolidation and attenuates posttraumatic stress response in rats. Biol Psychiatry 60, 767-776.
21. Cornelius, J.R., Kirisci, L., Reynolds, M., Clark, D.B., Hayes, J., and Tarter, R. (2010). PTSD contributes to teen and young adult cannabis use disorders. Addict Behav 35, 91-94.
22. Cougle, J.R., Bonn-Miller, M.O., Vujanovic, A.A., Zvolensky, M.J., and Hawkins, K.A. (2011). Posttraumatic stress disorder and cannabis use in a nationally representative sample. Psychol Addict Behav 25, 554-558.
23. Darves-Bornoz, J.M., Alonso, J., De Girolamo, G., De Graaf, R., Haro, J.M., Kovess-Masfety, V., Lepine, J.P., Nachbaur, G., Negre-Pages, L., Vilagut, G., and Gasquet, I. (2008). Main traumatic events in Europe: PTSD in the European study of the epidemiology of mental disorders survey. J Trauma Stress 21, 455-462.
24. De Oliveira Alvares, L., De Oliveira, L.F., Camboim, C., Diehl, F., Genro, B.P., Lanziotti, V.B., and Quillfeldt, J.A. (2005). Amnestic effect of intrahippocampal AM251, a CB1-selective blocker, in the inhibitory avoidance, but not in the open field habituation task, in rats. Neurobiol Learn Mem 83, 119-124.
25. De Oliveira Alvares, L., Pasqualini Genro, B., Diehl, F., Molina, V.A., and Quillfeldt, J.A. (2008). Opposite action of hippocampal CB1 receptors in memory reconsolidation and extinction. Neuroscience 154, 1648-1655.
26. De Quervain, D.J., Aerni, A., Schelling, G., and Roozendaal, B. (2009). Glucocorticoids and the regulation of emotional memory in health and disease. Front Neuroendocrinol 30, 358-370.
27. Di Marzo, V., De Petrocellis, L., and Bisogno, T. (2005). The biosynthesis, fate and pharmacological properties of endocannabinoids. Handb Exp Pharmacol, 147-185.
28. Dow, B., and Kline, N. (1997). Antidepressant treatment of posttraumatic stress disorder and major depression in veterans. Ann Clin Psychiatry 9, 1-5.
29. Economidou, D., Mattioli, L., Ubaldi, M., Lourdusamy, A., Soverchia, L., Hardiman, G., Campolongo, P., Cuomo, V., and Ciccocioppo, R. (2007). Role of cannabinoidergic mechanisms in ethanol self-administration and ethanol seeking in rat adult offspring following perinatal exposure to Delta9-tetrahydrocannabinol. Toxicol Appl Pharmacol 223, 73-85.
30. Egerton, A., Allison, C., Brett, R.R., and Pratt, J.A. (2006). Cannabinoids and prefrontal cortical function: insights from preclinical studies. Neurosci Biobehav Rev 30, 680-695.
31. Fernandez-Ruiz, J., Berrendero, F., Hernandez, M.L., and Ramos, J.A. (2000). The endogenous cannabinoid system and brain development. Trends Neurosci 23, 14-20.
32. Fraser, G.A. (2009). The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD). CNS Neurosci Ther 15, 84-88.
33. Ganon-Elazar, E., and Akirav, I. (2009). Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance. J Neurosci 29, 11078-11088.
34. Ganon-Elazar, E., and Akirav, I. (2012). Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress. Neuropsychopharmacology 37, 456-466.
35. Ganon-Elazar, E., and Akirav, I. (2013). Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit. Psychoneuroendocrinology.
36. Gobbi, G., Bambico, F.R., Mangieri, R., Bortolato, M., Campolongo, P., Solinas, M., Cassano, T., Morgese, M.G., Debonnel, G., Duranti, A., Tontini, A., Tarzia, G., Mor, M., Trezza, V., Goldberg, S.R., Cuomo, V., and Piomelli, D. (2005). Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci U S A 102, 18620-18625.
37. Goodman, J., Leong, K.C., and Packard, M.G. (2012). Emotional modulation of multiple memory systems: implications for the neurobiology of post-traumatic stress disorder. Rev Neurosci 23, 627-643.
38. Haller, J., Bakos, N., Szirmay, M., Ledent, C., and Freund, T.F. (2002). The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety. Eur J Neurosci 16, 1395-1398.
39. Haller, J., Varga, B., Ledent, C., Barna, I., and Freund, T.F. (2004). Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice. Eur J Neurosci 19, 1906-1912.
40. Harkany, T., Guzman, M., Galve-Roperh, I., Berghuis, P., Devi, L.A., and Mackie, K. (2007). The emerging functions of endocannabinoid signaling during CNS development. Trends Pharmacol Sci 28, 83-92.
41. Hauer, D., Ratano, P., Morena, M., Scaccianoce, S., Briegel, I., Palmery, M., Cuomo, V., Roozendaal, B., Schelling, G., and Campolongo, P. (2011). Propofol enhances memory formation via an interaction with the endocannabinoid system. Anesthesiology 114, 1380-1388.
42. Hauer, D., Schelling, G., Gola, H., Campolongo, P., Morath, J., Roozendaal, B., Hamuni, G., Karabatsiakis, A., Atsak, P., Vogeser, M., and Kolassa, I.T. (2013). Plasma concentrations of endocannabinoids and related primary Fatty Acid amides in patients with post-traumatic stress disorder. PLoS One 8, e62741.
43. Hemmings, H.C., Jr., and Mackie, K. (2011). The rivers of Lethe and Mnemosyne converge: propofol and memory consolidation. Anesthesiology 114, 1277-1279.
44. Herry, C., Ferraguti, F., Singewald, N., Letzkus, J.J., Ehrlich, I., and Luthi, A. (2010). Neuronal circuits of fear extinction. Eur J Neurosci 31, 599-612.
45. Hill, M.N., and Gorzalka, B.B. (2009). The endocannabinoid system and the treatment of mood and anxiety disorders. CNS Neurol Disord Drug Targets 8, 451-458.
46. Hirvonen, J., Goodwin, R.S., Li, C.T., Terry, G.E., Zoghbi, S.S., Morse, C., Pike, V.W., Volkow, N.D., Huestis, M.A., and Innis, R.B. (2012). Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Mol Psychiatry 17, 642-649.
47. Hughes, K.C., and Shin, L.M. (2011). Functional neuroimaging studies of post-traumatic stress disorder. Expert Rev Neurother 11, 275-285.
48. Ipser, J.C., Carey, P., Dhansay, Y., Fakier, N., Seedat, S., and Stein, D.J. (2006). Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders. Cochrane Database Syst Rev, CD005473.
49. Javidi, H., and Yadollahie, M. (2012). Post-traumatic Stress Disorder. Int J Occup Environ Med 3, 2-9.
50. Justinova, Z., Mangieri, R.A., Bortolato, M., Chefer, S.I., Mukhin, A.G., Clapper, J.R., King, A.R., Redhi, G.H., Yasar, S., Piomelli, D., and Goldberg, S.R. (2008). Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates. Biol Psychiatry 64, 930-937.
51. Kathuria, S., Gaetani, S., Fegley, D., Valino, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., La Rana, G., Calignano, A., Giustino, A., Tattoli, M., Palmery, M., Cuomo, V., and Piomelli, D. (2003). Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9, 76-81.
52. Kessler, R.C., Sonnega, A., Bromet, E., Hughes, M., and Nelson, C.B. (1995). Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 52, 1048-1060.
53. Layton, B., and Krikorian, R. (2002). Memory mechanisms in posttraumatic stress disorder. J Neuropsychiatry Clin Neurosci 14, 254-261.
54. Lutz, B. (2007). The endocannabinoid system and extinction learning. Mol Neurobiol 36, 92-101.
55. Marsicano, G., and Lafenetre, P. (2009). Roles of the endocannabinoid system in learning and memory. Curr Top Behav Neurosci 1, 201-230.
56. Marsicano, G., Wotjak, C.T., Azad, S.C., Bisogno, T., Rammes, G., Cascio, M.G., Hermann, H., Tang, J., Hofmann, C., Zieglgansberger, W., Di Marzo, V., and Lutz, B. (2002). The endogenous cannabinoid system controls extinction of aversive memories. Nature 418, 530-534.
57. Mcgaugh, J.L. (2004). The amygdala modulates the consolidation of memories of emotionally arousing experiences. Annu Rev Neurosci 27, 1-28.
58. Moreira, F.A., and Wotjak, C.T. (2010). Cannabinoids and anxiety. Curr Top Behav Neurosci 2, 429-450.
59. Neumeister, A. (2013). The endocannabinoid system provides an avenue for evidence-based treatment development for PTSD. Depress Anxiety 30, 93-96.
60. Neumeister, A., Normandin, M.D., Pietrzak, R.H., Piomelli, D., Zheng, M.Q., Gujarro-Anton, A., Potenza, M.N., Bailey, C.R., Lin, S.F., Najafzadeh, S., Ropchan, J., Henry, S., Corsi-Travali, S., Carson, R.E., and Huang, Y. (2013). Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. Mol Psychiatry. In press, doi: 10.1038/mp.2013.61.
61. Niyuhire, F., Varvel, S.A., Martin, B.R., and Lichtman, A.H. (2007). Exposure to marijuana smoke impairs memory retrieval in mice. J Pharmacol Exp Ther 322, 1067-1075.
62. Packard, M.G., and Goodman, J. (2012). Emotional arousal and multiple memory systems in the mammalian brain. Front Behav Neurosci 6, 14.
63. Pamplona, F.A., Bitencourt, R.M., and Takahashi, R.N. (2008). Short-and long-term effects of cannabinoids on the extinction of contextual fear memory in rats. Neurobiol Learn Mem 90, 290-293.
64. Parolaro, D., Realini, N., Vigano, D., Guidali, C., and Rubino, T. (2010). The endocannabinoid system and psychiatric disorders. Exp Neurol 224, 3-14.
65. Parsons, R.G., and Ressler, K.J. (2013). Implications of memory modulation for post-traumatic stress and fear disorders. Nat Neurosci 16, 146-153.
66. Passie, T., Emrich, H.M., Karst, M., Brandt, S.D., and Halpern, J.H. (2012). Mitigation of post-traumatic stress symptoms by Cannabis resin: a review of the clinical and neurobiological evidence. Drug Test Anal 4, 649-659.
67. Piomelli, D. (2003). The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4, 873-884.
68. Piomelli, D., Tarzia, G., Duranti, A., Tontini, A., Mor, M., Compton, T.R., Dasse, O., Monaghan, E.P., Parrott, J.A., and Putman, D. (2006). Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597). CNS Drug Rev 12, 21-38.
69. Quirk, G.J., and Mueller, D. (2008). Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 33, 56-72.
70. Riedel, G., and Davies, S.N. (2005). Cannabinoid function in learning, memory and plasticity. Handb Exp Pharmacol, 445-477.
71. Roozendaal, B., Barsegyan, A., and Lee, S. (2008). Adrenal stress hormones, amygdala activation, and memory for emotionally arousing experiences. Prog Brain Res 167, 79-97.
72. Ruehle, S., Rey, A.A., Remmers, F., and Lutz, B. (2012). The endocannabinoid system in anxiety, fear memory and habituation. J Psychopharmacol 26, 23-39.
73. Schelling, G., Stoll, C., Haller, M., Briegel, J., Manert, W., Hummel, T., Lenhart, A., Heyduck, M., Polasek, J., Meier, M., Preuss, U., Bullinger, M., Schuffel, W., and Peter, K. (1998). Health-related quality of life and posttraumatic stress disorder in survivors of the acute respiratory distress syndrome. Crit Care Med 26, 651-659.
74. Stern, C.A., Gazarini, L., Takahashi, R.N., Guimaraes, F.S., and Bertoglio, L.J. (2012). On disruption of fear memory by reconsolidation blockade: evidence from cannabidiol treatment. Neuropsychopharmacology 37, 2132-2142.
75. Stewart, S.H., Pihl, R.O., Conrod, P.J., and Dongier, M. (1998). Functional associations among trauma, PTSD, and substance-related disorders. Addict Behav 23, 797-812.
76. Tanda, G., and Goldberg, S.R. (2003). Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data. Psychopharmacology (Berl) 169, 115-134.
77. Trezza, V., Campolongo, P., Cassano, T., Macheda, T., Dipasquale, P., Carratu, M.R., Gaetani, S., and Cuomo, V. (2008). Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in Wistar rats. Psychopharmacology (Berl) 198, 529-537.
78. Usuki, M., Matsuoka, Y., Nishi, D., Yonemoto, N., Matsumura, K., Otomo, Y., Kim, Y., and Kanba, S. (2012). Potential impact of propofol immediately after motor vehicle accident on later symptoms of posttraumatic stress disorder at 6-month follow up: a retrospective cohort study. Crit Care 16, R196.
79. Van Ameringen, M., Mancini, C., Patterson, B., and Boyle, M.H. (2008). Post-traumatic stress disorder in Canada. CNS Neurosci Ther 14, 171-181.
80. Varvel, S.A., Wise, L.E., Niyuhire, F., Cravatt, B.F., and Lichtman, A.H. (2007). Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task. Neuropsychopharmacology 32, 1032-1041.
81. Vinod, K.Y., and Hungund, B.L. (2006). Role of the endocannabinoid system in depression and suicide. Trends Pharmacol Sci 27, 539-545.
82. Zohar, J., Juven-Wetzler, A., Sonnino, R., Cwikel-Hamzany, S., Balaban, E., and Cohen, H. (2011). New insights into secondary prevention in post-traumatic stress disorder. Dialogues Clin Neurosci 13, 301-309